Canada Life’s Aphria Inc. Common Shares APHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,140
Closed -$330K 2610
2021
Q1
$330K Sell
18,140
-16,200
-47% -$262K ﹤0.01% 1830
2020
Q4
$238K Buy
34,340
+354
+1% +$2.21K ﹤0.01% 1927
2020
Q3
$151K Sell
33,986
-399
-1% -$1.86K ﹤0.01% 1956
2020
Q2
$147K Buy
34,385
+2,654
+8% +$10.2K ﹤0.01% 1965
2020
Q1
$96K Buy
31,731
+675
+2% +$2.69K ﹤0.01% 1989
2019
Q4
$160K Buy
31,056
+26
+0.1% +$128 ﹤0.01% 1972
2019
Q3
$161K Sell
31,030
-15,229
-33% -$96.8K ﹤0.01% 991
2019
Q2
$325K Sell
46,259
-167
-0.4% -$1.26K ﹤0.01% 1908
2019
Q1
$432K Buy
46,426
+8,527
+22% +$74.9K ﹤0.01% 1678
2018
Q4
$212K Buy
+37,899
New +$299K ﹤0.01% 1924

Canada Life's APHA Position: Q2 2021 in Review

Canada Life sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 18,140 shares — an estimated $330K sold.

Canada Life first reported a position in APHA in Q4 2018 and held it in 10 quarters. The position peaked at $432K in Q1 2019. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

  • Canada Life reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Canada Life sold 18,140 Aphria Inc. Common Shares shares in Q2 2021, an estimated $330K.
  • Canada Life first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 10 quarters.
  • Canada Life's Aphria Inc. Common Shares position peaked at $432K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.